Additionally, lower total m6A levels in the myometrium of patients with adenomyosis have been linked to differential expression of METTL3 and ZC3H13 (206), suggesting that m6A RNA methylation regulatory factors may participate in the pathogenesis of adenomyosis through aberrant expression in the endometrium. The gene discussed is METTL3; the disease is adenomyosis.